Exact Mass: 602.4587

Exact Mass Matches: 602.4587

Found 96 metabolites which its exact mass value is equals to given mass value 602.4587, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

DG(14:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0)

(2S)-1-Hydroxy-3-(tetradecanoyloxy)propan-2-yl (6E,8Z,11Z,14Z)-5-oxoicosa-6,8,11,14-tetraenoic acid

C37H62O6 (602.4546)

DG(14:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(14:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/14:0/0:0)

(2S)-3-Hydroxy-2-(tetradecanoyloxy)propyl (6E,8Z,11Z,14Z)-5-oxoicosa-6,8,11,14-tetraenoic acid

C37H62O6 (602.4546)

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/14:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6E,8Z,11Z,14Z)+=O(5)/14:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(14:0/0:0/20:4(6E,8Z,11Z,14Z)+=O(5))

(2R)-2-Hydroxy-3-(tetradecanoyloxy)propyl (6E,8Z,11Z,14Z)-5-oxoicosa-6,8,11,14-tetraenoic acid

C37H62O6 (602.4546)

DG(14:0/0:0/20:4(6E,8Z,11Z,14Z)+=O(5)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/0:0/14:0)

(2S)-2-Hydroxy-3-(tetradecanoyloxy)propyl (6E,8Z,11Z,14Z)-5-oxoicosa-6,8,11,14-tetraenoic acid

C37H62O6 (602.4546)

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/0:0/14:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(14:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0)

(2S)-1-Hydroxy-3-(tetradecanoyloxy)propan-2-yl (5Z,8Z,11Z,13E)-15-oxoicosa-5,8,11,13-tetraenoic acid

C37H62O6 (602.4546)

DG(14:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(14:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/14:0/0:0)

(2S)-3-Hydroxy-2-(tetradecanoyloxy)propyl (5Z,8Z,11Z,13E)-15-oxoicosa-5,8,11,13-tetraenoic acid

C37H62O6 (602.4546)

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/14:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,13E)+=O(15)/14:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(14:0/0:0/20:4(5Z,8Z,11Z,13E)+=O(15))

(2R)-2-Hydroxy-3-(tetradecanoyloxy)propyl (5Z,8Z,11Z,13E)-15-oxoicosa-5,8,11,13-tetraenoic acid

C37H62O6 (602.4546)

DG(14:0/0:0/20:4(5Z,8Z,11Z,13E)+=O(15)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/0:0/14:0)

(2S)-2-Hydroxy-3-(tetradecanoyloxy)propyl (5Z,8Z,11Z,13E)-15-oxoicosa-5,8,11,13-tetraenoic acid

C37H62O6 (602.4546)

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/0:0/14:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(14:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0)

(2S)-1-Hydroxy-3-(tetradecanoyloxy)propan-2-yl (8Z,11Z,14Z,16E,18R)-18-hydroxyicosa-5,8,11,14,16-pentaenoic acid

C37H62O6 (602.4546)

DG(14:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(14:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/14:0/0:0)

(2S)-3-Hydroxy-2-(tetradecanoyloxy)propyl (8Z,11Z,14Z,16E,18S)-18-hydroxyicosa-5,8,11,14,16-pentaenoic acid

C37H62O6 (602.4546)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/14:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/14:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(14:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0)

(2R)-2-Hydroxy-3-(tetradecanoyloxy)propyl (8Z,11Z,14Z,16E,18S)-18-hydroxyicosa-5,8,11,14,16-pentaenoic acid

C37H62O6 (602.4546)

DG(14:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(14:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(i-14:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0)

(2S)-1-Hydroxy-3-[(12-methyltridecanoyl)oxy]propan-2-yl (6E,8Z,11Z,14Z)-5-oxoicosa-6,8,11,14-tetraenoic acid

C37H62O6 (602.4546)

DG(i-14:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-14:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/i-14:0/0:0)

(2S)-3-Hydroxy-2-[(12-methyltridecanoyl)oxy]propyl (6E,8Z,11Z,14Z)-5-oxoicosa-6,8,11,14-tetraenoic acid

C37H62O6 (602.4546)

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/i-14:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6E,8Z,11Z,14Z)+=O(5)/i-14:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(i-14:0/0:0/20:4(6E,8Z,11Z,14Z)+=O(5))

(2R)-2-Hydroxy-3-[(12-methyltridecanoyl)oxy]propyl (6E,8Z,11Z,14Z)-5-oxoicosa-6,8,11,14-tetraenoic acid

C37H62O6 (602.4546)

DG(i-14:0/0:0/20:4(6E,8Z,11Z,14Z)+=O(5)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/0:0/i-14:0)

(2S)-2-Hydroxy-3-[(12-methyltridecanoyl)oxy]propyl (6E,8Z,11Z,14Z)-5-oxoicosa-6,8,11,14-tetraenoic acid

C37H62O6 (602.4546)

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/0:0/i-14:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(i-14:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0)

(2S)-1-Hydroxy-3-[(12-methyltridecanoyl)oxy]propan-2-yl (5Z,8Z,11Z,13E)-15-oxoicosa-5,8,11,13-tetraenoic acid

C37H62O6 (602.4546)

DG(i-14:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-14:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/i-14:0/0:0)

(2S)-3-Hydroxy-2-[(12-methyltridecanoyl)oxy]propyl (5Z,8Z,11Z,13E)-15-oxoicosa-5,8,11,13-tetraenoic acid

C37H62O6 (602.4546)

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/i-14:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,13E)+=O(15)/i-14:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(i-14:0/0:0/20:4(5Z,8Z,11Z,13E)+=O(15))

(2R)-2-Hydroxy-3-[(12-methyltridecanoyl)oxy]propyl (5Z,8Z,11Z,13E)-15-oxoicosa-5,8,11,13-tetraenoic acid

C37H62O6 (602.4546)

DG(i-14:0/0:0/20:4(5Z,8Z,11Z,13E)+=O(15)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/0:0/i-14:0)

(2S)-2-Hydroxy-3-[(12-methyltridecanoyl)oxy]propyl (5Z,8Z,11Z,13E)-15-oxoicosa-5,8,11,13-tetraenoic acid

C37H62O6 (602.4546)

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/0:0/i-14:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(i-14:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0)

(2S)-1-Hydroxy-3-[(12-methyltridecanoyl)oxy]propan-2-yl (5Z,8Z,11Z,14Z,16E,18R)-18-hydroxyicosa-5,8,11,14,16-pentaenoic acid

C37H62O6 (602.4546)

DG(i-14:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-14:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/i-14:0/0:0)

(2S)-3-Hydroxy-2-[(12-methyltridecanoyl)oxy]propyl (5Z,8Z,11Z,14Z,16E,18S)-18-hydroxyicosa-5,8,11,14,16-pentaenoic acid

C37H62O6 (602.4546)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/i-14:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/i-14:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(i-14:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R))

(2R)-2-Hydroxy-3-[(12-methyltridecanoyl)oxy]propyl (5Z,8Z,11Z,14Z,16E,18S)-18-hydroxyicosa-5,8,11,14,16-pentaenoic acid

C37H62O6 (602.4546)

DG(i-14:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0/i-14:0)

(2S)-2-Hydroxy-3-[(12-methyltridecanoyl)oxy]propyl (5Z,8Z,11Z,14Z,16E,18S)-18-hydroxyicosa-5,8,11,14,16-pentaenoic acid

C37H62O6 (602.4546)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0/i-14:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(i-14:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0)

(2S)-1-Hydroxy-3-[(12-methyltridecanoyl)oxy]propan-2-yl (5Z,8Z,11Z,17Z)-16-hydroxyicosa-5,8,11,13,17-pentaenoic acid

C37H62O6 (602.4546)

DG(i-14:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-14:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/i-14:0/0:0)

(2S)-3-hydroxy-2-[(12-methyltridecanoyl)oxy]propyl (5Z,8Z,11Z,13E,17Z)-16-hydroxyicosa-5,8,11,13,17-pentaenoate

C37H62O6 (602.4546)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/i-14:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/i-14:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(i-14:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18))

(2R)-2-hydroxy-3-[(12-methyltridecanoyl)oxy]propyl (5Z,8Z,11Z,13E,17Z)-16-hydroxyicosa-5,8,11,13,17-pentaenoate

C37H62O6 (602.4546)

DG(i-14:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0/i-14:0)

(2S)-2-hydroxy-3-[(12-methyltridecanoyl)oxy]propyl (5Z,8Z,11Z,13E,17Z)-16-hydroxyicosa-5,8,11,13,17-pentaenoate

C37H62O6 (602.4546)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0/i-14:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(i-14:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0)

(2S)-1-hydroxy-3-[(12-methyltridecanoyl)oxy]propan-2-yl (5Z,8Z,10E,14Z,17Z)-12-hydroxyicosa-5,8,10,14,17-pentaenoate

C37H62O6 (602.4546)

DG(i-14:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-14:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/i-14:0/0:0)

(2S)-3-hydroxy-2-[(12-methyltridecanoyl)oxy]propyl (5Z,8Z,10E,14Z,17Z)-12-hydroxyicosa-5,8,10,14,17-pentaenoate

C37H62O6 (602.4546)

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/i-14:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/i-14:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(i-14:0/0:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12))

(2R)-2-hydroxy-3-[(12-methyltridecanoyl)oxy]propyl (5Z,8Z,10E,14Z,17Z)-12-hydroxyicosa-5,8,10,14,17-pentaenoate

C37H62O6 (602.4546)

DG(i-14:0/0:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0/i-14:0)

(2S)-2-hydroxy-3-[(12-methyltridecanoyl)oxy]propyl (5Z,8Z,10E,14Z,17Z)-12-hydroxyicosa-5,8,10,14,17-pentaenoate

C37H62O6 (602.4546)

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0/i-14:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(i-14:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0)

(2S)-1-Hydroxy-3-[(12-methyltridecanoyl)oxy]propan-2-yl (6E,8Z,11Z,14Z,17Z)-5-hydroxyicosa-6,8,11,14,17-pentaenoic acid

C37H62O6 (602.4546)

DG(i-14:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-14:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/i-14:0/0:0)

(2S)-3-Hydroxy-2-[(12-methyltridecanoyl)oxy]propyl (6E,8Z,11Z,14Z,17Z)-5-hydroxyicosa-6,8,11,14,17-pentaenoic acid

C37H62O6 (602.4546)

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/i-14:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/i-14:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(i-14:0/0:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5))

(2R)-2-Hydroxy-3-[(12-methyltridecanoyl)oxy]propyl (6E,8Z,11Z,14Z,17Z)-5-hydroxyicosa-6,8,11,14,17-pentaenoic acid

C37H62O6 (602.4546)

DG(i-14:0/0:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0/i-14:0)

(2S)-2-Hydroxy-3-[(12-methyltridecanoyl)oxy]propyl (6E,8Z,11Z,14Z,17Z)-5-hydroxyicosa-6,8,11,14,17-pentaenoic acid

C37H62O6 (602.4546)

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0/i-14:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

Calcium oleate

Calcium bis((9E)-octadec-9-enoic acid)

C36H66CaO4 (602.4587)

It is used as a food additive .

(E,9R,11R)-9,11-dihydroxy-29-(4-hydroxyphenyl)-2,4-dimethyl-3-oxononacos-4-enoic acid

C37H62O6 (602.4546)

DG(14:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0)

C37H62O6 (602.4546)

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/14:0/0:0)

C37H62O6 (602.4546)

DG(14:0/0:0/20:4(6E,8Z,11Z,14Z)+=O(5))

C37H62O6 (602.4546)

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/0:0/14:0)

C37H62O6 (602.4546)

DG(i-14:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0)

C37H62O6 (602.4546)

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/i-14:0/0:0)

C37H62O6 (602.4546)

DG(i-14:0/0:0/20:4(6E,8Z,11Z,14Z)+=O(5))

C37H62O6 (602.4546)

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/0:0/i-14:0)

C37H62O6 (602.4546)

DG(14:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0)

C37H62O6 (602.4546)

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/14:0/0:0)

C37H62O6 (602.4546)

DG(14:0/0:0/20:4(5Z,8Z,11Z,13E)+=O(15))

C37H62O6 (602.4546)

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/0:0/14:0)

C37H62O6 (602.4546)

DG(14:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0)

C37H62O6 (602.4546)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/14:0/0:0)

C37H62O6 (602.4546)

DG(i-14:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0)

C37H62O6 (602.4546)

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/i-14:0/0:0)

C37H62O6 (602.4546)

DG(i-14:0/0:0/20:4(5Z,8Z,11Z,13E)+=O(15))

C37H62O6 (602.4546)

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/0:0/i-14:0)

C37H62O6 (602.4546)

DG(i-14:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0)

C37H62O6 (602.4546)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/i-14:0/0:0)

C37H62O6 (602.4546)

DG(i-14:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R))

C37H62O6 (602.4546)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0/i-14:0)

C37H62O6 (602.4546)

DG(i-14:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0)

C37H62O6 (602.4546)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/i-14:0/0:0)

C37H62O6 (602.4546)

DG(i-14:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18))

C37H62O6 (602.4546)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0/i-14:0)

C37H62O6 (602.4546)

DG(i-14:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0)

C37H62O6 (602.4546)

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/i-14:0/0:0)

C37H62O6 (602.4546)

DG(i-14:0/0:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12))

C37H62O6 (602.4546)

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0/i-14:0)

C37H62O6 (602.4546)

DG(i-14:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0)

C37H62O6 (602.4546)

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/i-14:0/0:0)

C37H62O6 (602.4546)

DG(i-14:0/0:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5))

C37H62O6 (602.4546)

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0/i-14:0)

C37H62O6 (602.4546)

DG(14:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0)

C37H62O6 (602.4546)

Marianoside B

C37H62O6 (602.4546)

A triterpene glycoside that is lanost-8-ene substituted by a methylidene group at position 24 and a beta-D-glucopyranosyloxy group at position 3. Isolated from the whole plant of Silybum marianum, it exhibits inhibitory activity against chymotrypsin.

NAOrn 18:4/13:0

C36H62N2O5 (602.4658)

NAOrn 16:3/15:1

C36H62N2O5 (602.4658)

NAOrn 15:1/16:3

C36H62N2O5 (602.4658)

NAOrn 18:3/13:1

C36H62N2O5 (602.4658)

NAOrn 16:4/15:0

C36H62N2O5 (602.4658)

NAOrn 11:0/20:4

C36H62N2O5 (602.4658)

NAOrn 13:1/18:3

C36H62N2O5 (602.4658)

NAOrn 20:4/11:0

C36H62N2O5 (602.4658)

2,3-di(octanoyloxy)propyl (6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoate

C37H62O6 (602.4546)

2,3-di(nonanoyloxy)propyl (4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoate

C37H62O6 (602.4546)

(2-decanoyloxy-3-octanoyloxypropyl) (4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoate

C37H62O6 (602.4546)

2-[Carboxy-(3-nonanoyloxy-2-tetradecanoyloxypropoxy)methoxy]ethyl-trimethylazanium

C33H64NO8+ (602.4632)

2-[Carboxy-(2-dodecanoyloxy-3-undecanoyloxypropoxy)methoxy]ethyl-trimethylazanium

C33H64NO8+ (602.4632)

2-[Carboxy-(3-decanoyloxy-2-tridecanoyloxypropoxy)methoxy]ethyl-trimethylazanium

C33H64NO8+ (602.4632)

2-[Carboxy-(3-octanoyloxy-2-pentadecanoyloxypropoxy)methoxy]ethyl-trimethylazanium

C33H64NO8+ (602.4632)

TG(34:4)

TG(6:0_14:2_14:2)

C37H62O6 (602.4546)

NA-Orn 31:4

C36H62N2O5 (602.4658)

CAE 13:1

C37H62O6 (602.4546)

(2r,3r,4s,5s,6r)-2-{[(1r,3ar,5as,7s,9ar,11ar)-3a,6,6,9a,11a-pentamethyl-1-[(2r)-6-methyl-5-methylideneheptan-2-yl]-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6r)-2-{[(1r,3ar,5as,7s,9ar,11ar)-3a,6,6,9a,11a-pentamethyl-1-[(2r)-6-methyl-5-methylideneheptan-2-yl]-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C37H62O6 (602.4546)

2-{[3a,6,6,9a,11a-pentamethyl-1-(6-methyl-5-methylideneheptan-2-yl)-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C37H62O6 (602.4546)